How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsMichaele C. Christian, Edward L. Trimble, Jeffrey S. Abrams et al.|Journal of Clinical Oncology|2002Cited by 531
Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment TrialsHugo A. Tejeda, Otis W. Brawley, S. B. Green et al.|JNCI Journal of the National Cancer Institute|1996Cited by 275
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M. Jaffee, Richard Sullivan, Jeffrey A. Bluestone et al.|The Lancet Oncology|2017Cited by 209
Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalitionBob T. Li, Yi‐Long Wu, Bobby Daly et al.|Nature Medicine|2022Cited by 52
Equal Participation of Minority Patients in U.S. National Pediatric Cancer Clinical TrialsW. Archie Bleyer, Richard S. Ungerleider, Heriberto A. Tejeda et al.|Journal of Pediatric Hematology/Oncology|1997Cited by 43